Middle East & Africa Spatial Genomics & Transcriptomics Market Size & Outlook
- Biotechnology
- Genomics & Genetic Engineering
- Spatial Genomics & Transcriptomics Market Outlook
- Genomics & Genetic Engineering
Middle East Africa Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the spatial genomics & transcriptomics market
MEA spatial genomics & transcriptomics market highlights
- The MEA spatial genomics & transcriptomics market generated a revenue of USD 6.3 million in 2023.
- The market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 6.3 million |
| Market revenue in 2030 | USD 9.5 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.0% of the global spatial genomics & transcriptomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 139.0 million by 2030.
Cancer is a major public health concern in MEA. High mortality associated with unavailability of resources, such as diagnostics, underdeveloped healthcare infrastructure, and lack of affordable treatment options makes MEA a preferred region for investments by large manufacturers. However, low adoption of genomic-based techniques is anticipated to impede the market growth to some extent in the region.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Natera Inc | View profile | 3,293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | www.natera.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | www.horizondiscovery.com |
| Dovetail Genomics | View profile | 11-50 | Scotts Valley, California, United States, North America | dovetailgenomics.com/ |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | www.nanostring.com |
| Seven Bridges | View profile | 251-500 | Charlestown, Massachusetts, United States, North America | www.sevenbridges.com/ |
| S2 Genomics | View profile | 11-50 | Livermore, California, United States, North America | s2genomics.com |
Middle East & Africa Spatial Genomics & Transcriptomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Spatial Genomics & Transcriptomics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 53.97% in 2023.
Horizon Databook has segmented the Middle East & Africa spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
Cancer is a major public health concern in MEA. High mortality associated with unavailability of resources, such as diagnostics, underdeveloped healthcare infrastructure, and lack of affordable treatment options makes MEA a preferred region for investments by large manufacturers. However, low adoption of genomic-based techniques is anticipated to impede the market growth to some extent in the region.
- Middle East & Africa Spatial Genomics & Transcriptomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Instruments
- Consumables
- Software
- Middle East & Africa Spatial Genomics & Transcriptomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Spatial Transcriptomics
- Spatial Genomics
- Middle East & Africa Spatial Genomics & Transcriptomics Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Translational Research
- Academic Customers
- Diagnostic Customers
- Pharmaceutical Manufacturer
Reasons to subscribe to Spatial Genomics & Transcriptomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spatial Genomics & Transcriptomics Market Outlook databook
- Our clientele includes a mix of Spatial Genomics & Transcriptomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Spatial Genomics & Transcriptomics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Spatial Genomics & Transcriptomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
MEA spatial genomics & transcriptomics market statistics, by product, 2018-2030 (US$M)
